It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Non-polyadenylated mRNAs of replication-dependent histones (RDHs) are synthesized by RNA polymerase II (Pol II) at histone locus bodies (HLBs). HLBs frequently associate with Cajal bodies (CBs), in which 3′-end processing factors for RDH genes are enriched; however, this association’s role in transcription termination of RDH genes remains unclear. Here, we show that Pol II pauses immediately upstream of transcript end sites of RDH genes and Mediator plays a role in this Pol II pausing through CBs’ association with HLBs. Disruption of the Mediator docking site for Little elongation complex (LEC)–Cap binding complex (CBC)–Negative elongation factor (NELF), components of CBs, interferes with CBs’ association with HLBs and 3′ Pol II pausing, resulting in increased aberrant unprocessed RDH gene transcripts. Our findings suggest Mediator’s involvement in CBs’ association with HLBs to facilitate 3′ Pol II pausing and subsequent 3′-end processing of RDH genes by supplying 3′-end processing factors.
Transcription termination is generally accompanied by the 3′-end processing of transcripts. Here the authors demonstrate a role for Mediator in transcript end site proximal pausing of replication-dependent histone genes.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Yokohama City University Graduate School of Medical Science, Department of Molecular Biology, Yokohama, Japan (GRID:grid.268441.d) (ISNI:0000 0001 1033 6139)
2 Tokyo Institute of Technology, School of Life Science and Technology, Yokohama, Japan (GRID:grid.32197.3e) (ISNI:0000 0001 2179 2105)
3 National Institute of Genetics, Comparative Genomics Laboratory, Shizuoka, Japan (GRID:grid.288127.6) (ISNI:0000 0004 0466 9350)
4 The University of Tokyo, Laboratory of Systems Genomics, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, Chiba, Japan (GRID:grid.26999.3d) (ISNI:0000 0001 2151 536X)
5 The Cancer Institute of JFCR, Division of Cancer Biology, Tokyo, Japan (GRID:grid.486756.e) (ISNI:0000 0004 0443 165X)
6 Stowers Institute for Medical Research, Kansas City, USA (GRID:grid.250820.d) (ISNI:0000 0000 9420 1591)
7 Stowers Institute for Medical Research, Kansas City, USA (GRID:grid.250820.d) (ISNI:0000 0000 9420 1591); University of Kansas Medical Center, Department of Biochemistry & Molecular Biology, Kansas City, USA (GRID:grid.412016.0) (ISNI:0000 0001 2177 6375)